Our laboratory is interested in improving treatment for patients with glioblastoma (GBM) and other cancers. We work on understanding signal transduction pathways involved in the pathogenesis of cancer. Recent work has focused on investigating mechanisms of resistance to targeted treatment in GBM and lung cancer. We are also interested in mechanisms regulating invasion in GBM. 

The goal of our research is to identify key immune checkpoints of gastrointestinal disorders that could be targeted for therapeutic intervention and drug development.

Welcome to the PARK Lab.

Our lab focuses on:

1. Development of novel noninvasive imaging methods for in vivo metabolism and function
2. Identification of characteristics in metabolic diseases in vivo and ex vivo
3. Clinical translations of the metabolic imaging methods